COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT05667077


Column Value
Trial registration number NCT05667077
Full text link
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

First author
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

None

Contact
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

None

Registration date
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

2022-12-28

Recruitment status
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Not recruiting

Study design
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

inclusion criteria: clinical diagnosis of covid-19 clinical evidence of fatigue despite the passage of 30 to 60 days from the onset --of the symptoms of covid-19 willingness and informed consent to participate in the study

Exclusion criteria
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

the recurrence of covid-19 in the form of re-infection history of psychiatric diseases psychotic disorders (in the form of hallucinations and delusions) anxiety disorders and major depression substance abuse in the last four months taking antidepressants during the last six weeks corticosteroids consumption during the last six weeks taking psychostimulant drugs an unstable medical condition cognitive disorders and confusion withdrawal from participating in the study history of rheumatological disease getting cancer and malignancy advanced chronic diseases (heart, liver, kidney, etc.) edema of organs hypertension (untreated) hypogonadism (untreated) hypothyroidism (untreated) anemia (untreated) pregnancy and breastfeeding nausea and vomiting when starting to take amantadine convulsions dyspnea post-covid-19 encephalopathy

Number of arms
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

2

Funding
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Shahid Beheshti University of Medical Sciences

Inclusion age min
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

20

Inclusion age max
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

50

Countries
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Iran;Islamic Republic of

Type of patients
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

83

primary outcome
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Fatigue Severity Scale (FSS);Visual Analog Fatigue Scale (VAFS)

Notes
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

None

Phase
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

Phase 2

Arms
Last imported at : Jan. 2, 2023, noon
Source : ClinicalTrials.gov

[{"arm_notes": "nan", "treatment_id": 74, "treatment_name": "Amantadine", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]